NCT06215027 The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment
| NCT ID | NCT06215027 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AC Camargo Cancer Center |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2025-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-02-01 with a primary completion date of 2025-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this non randomized clinical trial, with pre- and post-intervention evaluation, longitudinal, with prospective data collection is to evaluate the effects of dance as a therapeutic intervention in breast cancer patients undergoing surgical treatment.
Eligibility Criteria
Inclusion Criteria: * patients diagnosed with breast cancer * undergone surgical resection * after medical referral for physiotherapy * and physiotherapeutic assessment Exclusion Criteria: * patients with another previous oncological diagnosis * previous neuromuscular diseases * patients who do not agree to take part in the study * or the impossibility of carrying out the muscle strength assessment and/or other assessments
Contact & Investigator
Letícia Cardenas, PHD
PRINCIPAL INVESTIGATOR
AC Camargo Cancer Center
Frequently Asked Questions
Who can join the NCT06215027 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06215027 currently recruiting?
Yes, NCT06215027 is actively recruiting participants. Contact the research team at leticia.cardenas@accamargo.org.br for enrollment information.
Where is the NCT06215027 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT06215027 clinical trial?
NCT06215027 is sponsored by AC Camargo Cancer Center. The principal investigator is Letícia Cardenas, PHD at AC Camargo Cancer Center. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.